Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

Cancer Genetics Risk Assessment and Counseling (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf

A new paradigm of genetic testing for hereditary breast/ovarian cancers

Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes, Hereditary Cancer in Clinical Practice

media.springer/full/springer-static/imag

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

Whole genome sequencing of breast cancer - Rossing - 2019 - APMIS - Wiley Online Library

Frontiers Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine

Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group

Cancers, Free Full-Text